Fundraising FoxKilele Health
Oakwood, US · Founded 2023 · Delaware corporation · 1 known investors
Find your way into Kilele Health
Sign up to see every warm intro you have to Kilele Health
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kilele Health team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kilele Health develops biosensing medical devices for patient monitoring and diagnostics. The company combines advanced biosensing technology with expertise in medtech development and commercialization to serve healthcare providers and patients.
Founders & leadership
Kilele Health was founded in 2023 by Andrew Cothrel, Jason Heikenfeld, and Jason Heikenfeld, PhD.
AC
Andrew CothrelCEO and Co-FounderAndrew Cothrel has spent 20 years in senior roles at Fortune 100 companies developing and launching healthcare and medical device products, followed by 18 years in startups, consulting, and venture focused on commercializing novel technology across medical, life sciences, and cleantech sectors. He brings experience in product development, regulatory strategy, partnerships, and commercialization across diagnostics, monitoring devices, and medical robotics.
JH
Jason Heikenfeld, PhDChief Technology Officer and Co-Founder
SS
Sven SchreiberChief Product OfficerSven Schreiber is an operations leader with project management experience in biotechnology, pharmaceuticals, and consumer products, including process transfer, scale-up, and continuous improvement work. He holds a Six Sigma Green Belt certification and has expertise in FDA quality systems and lean manufacturing principles.
BN
Brittany Nicole ArdeExecutive
Investors · 1
Reported raises · per SEC filings
Form D private placements$264.5K disclosed across 1 of 3 rounds · 2023–2025
▶$264.5KraisedOct 2025 · 3 investors · BiotechnologyRule 506(b)
▶$264.5KraisedOct 2025 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jason Charles HeikenfeldExecutive Officer, Director, Promoter
- Sven SchreiberExecutive Officer
- Andrew David CothrelExecutive Officer, Director, Promoter
- Brittany Nicole ArdeExecutive Officer
- Offering amount
- $2M
- Amount sold
- $264.5K
- Minimum investment
- $48K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Current HealthCurrent Health builds FDA-cleared clinical technology and infrastructure that enables acute and complex care—including advanced therapies like CAR-T, bispecifics, and cell and gene therapies—to be delivered safely in ambulatory and home settings. It works with health systems and global pharmaceutical companies to expand patient access to high-cost treatments outside traditional hospital settings.
Kangaroo HealthKangaroo Health provides a remote patient monitoring platform for chronic disease management, serving healthcare organizations and clinical providers. The company offers clinical monitoring, personalized care pathways, and billing support for 50+ chronic conditions.
Israel Israel IsraelK Health provides an agentic clinical AI platform for health systems, offering symptom investigation, patient triage, and automated documentation integrated into Epic and MyChart. It supports fully integrated primary care through consumer intake tools, provider-facing workflow support, and a 24/7 virtual clinic staffed by credentialed providers, serving U.S. health systems.
Zip DrugZipdrug is a prescription delivery and pharmacy benefit platform, acquired by Anthem's PBM IngenioRx in 2020.
Sibel HealthSibel Health develops medical monitoring products that capture vital signs and health data to support clinical decisions in both patient care and clinical trials. Its technology is aimed at improving decision-making for drug safety, efficacy, and clinical treatment.
Companies working in the same space as Kilele Health.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase ISTTR | 2022 | $255.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Kilele Health do?
- Kilele Health develops biosensing medical devices for patient monitoring and diagnostics. The company combines advanced biosensing technology with expertise in medtech development and commercialization to serve healthcare providers and patients.
- Who founded Kilele Health?
- Kilele Health was founded by Andrew Cothrel, Jason Heikenfeld, Jason Heikenfeld, PhD in 2023.
- Who are Kilele Health's investors?
- Kilele Health's investors include JumpStart Equity.
- How much funding has Kilele Health raised?
- Kilele Health has disclosed $264.5K raised across 1 of its 3 known rounds.
- Where is Kilele Health headquartered?
- Kilele Health is headquartered in Oakwood, US.